The European Medicines Agency (EMA) has organised a public meeting on 11 December 2020 to inform European citizens about the EU regulatory processes for the approval of COVID-19 vaccines. The EMA will also discuss their role in the development, evaluation, approval and safety monitoring of the vaccines.
The public meeting will be broadcast live and will be open to all citizens. It will be an opportunity for the public and stakeholders to share their needs, expectations and concerns which the EMA and the European medicines regulatory network can consider in their decision-making processes.
Español
English
